Medmira Capital Ltd.

Insider Reports History

Entity
Company
Location
16 F Beike Building, 59 Gaoxin Nanjiu Rd, Shenzhen, China
Signature
/s/ Nicole Valdivieso, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Medmira Capital Ltd.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
HCW Biologics Inc. 10%+ Owner Common Stock 0 $2.08 Sep 15, 2021 Direct

Insider Reports Filed by Medmira Capital Ltd.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
HCWB HCW Biologics Inc. Sep 15, 2021 1 $0 4 Sep 17, 2021 10%+ Owner
HCWB HCW Biologics Inc. Jul 22, 2021 4 $0 4 Jul 23, 2021 10%+ Owner
HCWB HCW Biologics Inc. Jul 19, 2021 0 $0 3 Jul 19, 2021 10%+ Owner